Evaluation of the effects of supplementation extract prepared from Capparis spinosa on clinical manifestations in patients with refractory rheumatoid arthritis.
Phase 2
- Conditions
- Rheumatoid arthritis.Rheumatoid arthritis with rheumatoid factor
- Registration Number
- IRCT20151028024760N5
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Resistant rheumatoid arthritis (RA) patients to non-biological disease-modifying anti-rheumatic drugs (DMARDs) Treated RA patients by non-biological drugs Treated RA patients by Prednisolone, Hydroxychloroquine, Sulfasalazine and Methotrexate Refractory RA patients with no other Rheumatic disorders and inflammatory diseases
Exclusion Criteria
Non-resistant RA patients to non-biological disease-modifying anti-rheumatic drugs (DMARDs)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method